Resources

As Antibody Drug Conjugates (ADCs) become the future standard of cancer therapy, Simtra BioPharma Solutions is a trusted partner for Pharmaceutical and Biotech companies developing complex therapies.

Both our Bloomington and Halle/Westfalen facilities have earned numerous industry awards for manufacturing excellence in various categories over the last two decades.

As a premier independent contract development and manufacturing (CDMO), Simtra helps pharmaceutical and biotechnology companies develop and produce high quality sterile injectables for their patients globally.

With a focus on the future, Simtra is expanding capacity and capabilities at both of its facilities.

At Simtra, we make what matters. No matter the challenge, a Simtra expert is there to help meet it. We are made for this.

Simtra is a contract development and manufacturing organization with a singular focus on sterile injectables.

Simtra BioPharma Solutions separated from Baxter in October 2023 and became an independent company with robust expansion plans.

Simtra offers a full range of customized product development capabilities and is expanding its clinical manufacturing capacity.

Simtra understands the root causes of vial breakage during lyophilization and can apply mitigation strategies to avoid it.